Drug recall · April 22, 2015
Cartia XT recall
Why: Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90
- Lots / codes
Lot # 956000M, Exp. Aug 2016; UPC 3-6203760090-6
- Quantity
- 2,628 bottles
- Company
- Actavis Laboratories, FL, Inc., Davie, FL
- Distribution
- Nationwide
- Initiated
- March 26, 2015 · Voluntary: Firm initiated
- Classified
- April 15, 2015
- Reported
- April 22, 2015
- Ended
- December 30, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cartia
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.